Recently the FDA finally agreed to step into the foray regarding infusion pumps because of increasing reports of preventable death, leading to more and more medical malpractice actions. Infusion pumps have been increasingly involved in adverse patient outcomes that lead to medical malpractice suits and very large settlements or verdicts. Infusion pumps pump medications and solutions, and when they don't function properly, patients can be overdosed, leading to death or disability. In fact, in the past 5 years the FDA has received reports of 710 patient deaths associated with malfunctioning infusion pumps.
To read the entire NY Times article, CLICK HERE.
